GDF15 and type 2 diabetes mellitus: In a study including 861 patients with T2D and advanced nephropathy (mean eGFR 33 ml/min/1.73m2), no association was found between GDF-15 and the composite CV endpoint including CV mortality (event rate 12.4%) after adjustment for traditional risk factors comparable to our adjustment[18].